Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.
about
Update in genetic susceptibility in melanomaDiscussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing.Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based DifferencesPerceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.Family risk discussions after feedback on genetic risk of melanomaUnaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.Impact of melanoma genetic test reporting on perceived control over melanoma preventionGenetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling aloneA systematic review of interventions to improve adherence to melanoma preventive behaviors for individuals at elevated risk.Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Clinical applications of melanoma genetics.Blue Genes? Understanding and Mitigating Negative Consequences of Personalized Information about Genetic Risk for Depression.Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
P2860
Q26778756-D045BA9D-F4A9-43E6-9B0A-C5BF6B318683Q30203298-AA86118F-D4A0-4C46-96E0-C7B23729ED1EQ30696780-8ED6AC25-5D0E-44EA-B11F-D39C080FC244Q33638941-98D5E54D-CDE0-49EE-A05F-A16A80137740Q33878499-650E74B3-AF9D-49B8-A4A1-E1FC5095EE71Q34401911-F7E7D8D4-A833-4BAB-A88A-361C8D97302CQ34515007-35837B4E-10AD-40A8-B99F-BCF31CAD392DQ35392953-B8AFFCB7-C086-41BE-A528-C4EAFA00EEBBQ36055045-8988C327-BA74-4B8E-9920-AF74F61FD9CDQ36055213-8781568F-A546-4FBF-8E8C-7DE0B5C127B0Q36993925-40F8C2DE-9893-4A1C-9937-0A4FB1487954Q37083946-195A969D-E266-4CBA-A51E-EFBAE4FC59B9Q38197938-50DCE8AA-753D-427D-B8F7-EBF3C5CFE83EQ47652242-3E0A70D9-008E-45DF-A4A2-E91D093A5073Q48212957-9C9D5C22-C874-4137-9D09-C6FE7B193317Q49551579-0B5F4A16-D19A-45B1-9318-C6978314A01B
P2860
Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melanoma genetic counseling an ...... fected carriers 2 years later.
@en
Melanoma genetic counseling an ...... fected carriers 2 years later.
@nl
type
label
Melanoma genetic counseling an ...... fected carriers 2 years later.
@en
Melanoma genetic counseling an ...... fected carriers 2 years later.
@nl
prefLabel
Melanoma genetic counseling an ...... fected carriers 2 years later.
@en
Melanoma genetic counseling an ...... fected carriers 2 years later.
@nl
P2093
P2860
P1476
Melanoma genetic counseling an ...... fected carriers 2 years later.
@en
P2093
Jennifer M Taber
Lisa G Aspinwall
Samantha L Leaf
Sancy A Leachman
Wendy Kohlmann
P2860
P304
P356
10.1158/1055-9965.EPI-13-0422
P577
2013-08-15T00:00:00Z